Toward identifying key mechanisms of progression in multiple sclerosis-Reference-Cited by-同舟云学术

Toward identifying key mechanisms of progression in multiple sclerosis

Published:2024-01 Issue:1 Volume:47 Page:58-70
ISSN:0166-2236
Container-title:Trends in Neurosciences
language:en
Short-container-title:Trends in Neurosciences

Author:

Husseini Leila,Geladaris Anastasia,Weber Martin S.

Funder

Universitätsmedizin Göttingen

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

General Neuroscience

Reference124 articles.

1. Multiple Sclerosis Collaborators (2019) Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016;GBD;Lancet Neurol.,2016

2. Multiple sclerosis: an immune or neurodegenerative disorder?;Trapp;Annu. Rev. Neurosci.,2008

3. The influence of age at disease onset on future relapses and disability progression in multiple sclerosis patients on immunomodulatory treatment;von Wyl;Eur. J. Neurol.,2020

4. The natural history of primary progressive multiple sclerosis;Koch;Neurology,2009

5. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?;Antel;Acta Neuropathol.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Psychological Stress on Multiple Sclerosis via HPA Axis-mediated Modulation of Natural Killer T Cell Activity;CNS & Neurological Disorders - Drug Targets;2024-12

2. NINJ1: A new player in multiple sclerosis pathogenesis and potential therapeutic target;International Immunopharmacology;2024-11

3. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course;The Lancet Regional Health - Europe;2024-09

4. Primary Progressive Multiple Sclerosis—A Key to Understanding and Managing Disease Progression;International Journal of Molecular Sciences;2024-08-11

5. Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesis;Multiple Sclerosis and Related Disorders;2024-08